161 related articles for article (PubMed ID: 30410139)
1. Tumour Lysis Syndrome in children with haematological cancers: Experience at a tertiary care hospital in Karachi.
Saeed F; Ali MS; Ashraf MS; Vadsaria K; Siddiqui DE
J Pak Med Assoc; 2018 Nov; 68(11):1625-1630. PubMed ID: 30410139
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of the safety and efficacy of low-dose rasburicase in critically ill children with haematological malignancies.
Pei Y; Li Y; Liang Y; Xu L; Huang X; Li Y; Tang W; Jiang X
Int J Clin Pharm; 2020 Dec; 42(6):1440-1446. PubMed ID: 32974856
[TBL] [Abstract][Full Text] [Related]
3. Guidelines for the management of tumour lysis syndrome in adults and children with haematological malignancies on behalf of the British Committee for Standards in Haematology.
Jones GL; Will A; Jackson GH; Webb NJ; Rule S;
Br J Haematol; 2015 Jun; 169(5):661-71. PubMed ID: 25876990
[No Abstract] [Full Text] [Related]
4. [Tumour lysis syndrome in small-cell lung cancer].
Boshuizen RC; Smit AA; Moons-Pasic A; Bresser P
Ned Tijdschr Geneeskd; 2016; 160():A9823. PubMed ID: 27334081
[TBL] [Abstract][Full Text] [Related]
5. Incidence of chemotherapy-related tumour lysis syndrome at Kenyatta National Hospital, Nairobi.
Busakhala W; Joshi MD; Abinya NO; Amayo A; Abwao HO
East Afr Med J; 2007 Mar; 84(3):100-9. PubMed ID: 17600978
[TBL] [Abstract][Full Text] [Related]
6. Pan-European multicentre economic evaluation of recombinant urate oxidase (rasburicase) in prevention and treatment of hyperuricaemia and tumour lysis syndrome in haematological cancer patients.
Annemans L; Moeremans K; Lamotte M; Garcia Conde J; van den Berg H; Myint H; Pieters R; Uyttebroeck A
Support Care Cancer; 2003 Apr; 11(4):249-57. PubMed ID: 12673464
[TBL] [Abstract][Full Text] [Related]
7. Tumour lysis syndrome as a rare complication of chemotherapy in paediatric Wilms' Tumour: a case report.
Qamar S; Sindhu II; Shaheen N
J Pak Med Assoc; 2023 Mar; 73(3):700-704. PubMed ID: 36932788
[TBL] [Abstract][Full Text] [Related]
8. The clinical management of tumour lysis syndrome in haematological malignancies.
Will A; Tholouli E
Br J Haematol; 2011 Jul; 154(1):3-13. PubMed ID: 21554259
[TBL] [Abstract][Full Text] [Related]
9. Clinical versus laboratory tumor lysis syndrome in children with acute leukemia.
Kedar A; Grow W; Neiberger RE
Pediatr Hematol Oncol; 1995; 12(2):129-34. PubMed ID: 7626380
[TBL] [Abstract][Full Text] [Related]
10. Tumour lysis syndrome and acute kidney injury in high-risk haematology patients in the rasburicase era. A prospective multicentre study from the Groupe de Recherche en Réanimation Respiratoire et Onco-Hématologique.
Darmon M; Vincent F; Camous L; Canet E; Bonmati C; Braun T; Caillot D; Cornillon J; Dimicoli S; Etienne A; Galicier L; Garnier A; Girault S; Hunault-Berger M; Marolleau JP; Moreau P; Raffoux E; Recher C; Thiebaud A; Thieblemont C; Azoulay E;
Br J Haematol; 2013 Aug; 162(4):489-97. PubMed ID: 23772757
[TBL] [Abstract][Full Text] [Related]
11. Tumour lysis syndrome in a patient with intravascular spread from a recurrent epithelial ovarian cancer.
Camarata M; Davies R; Copley S; Blagden S
BMJ Case Rep; 2013 Apr; 2013():. PubMed ID: 23616333
[TBL] [Abstract][Full Text] [Related]
12. Tumour lysis syndrome in haematological malignancies.
van der Hoven B; Thunnissen PL; Sizoo W
Neth J Med; 1992 Feb; 40(1-2):31-5. PubMed ID: 1579184
[TBL] [Abstract][Full Text] [Related]
13. Risk-based management strategy and outcomes of tumor lysis syndrome in children with leukemia/lymphoma: Analysis from a resource-limited setting.
Gopakumar KG; Seetharam S; Km JK; Nair M; Rajeswari B; Cs G; Vr P; Thankamony P
Pediatr Blood Cancer; 2018 Dec; 65(12):e27401. PubMed ID: 30101454
[TBL] [Abstract][Full Text] [Related]
14. Febuxostat as a Prophylaxis for Tumor Lysis Syndrome in Children with Hematological Malignancies.
Kishimoto K; Kobayashi R; Hori D; Sano H; Suzuki D; Kobayashi K
Anticancer Res; 2017 Oct; 37(10):5845-5849. PubMed ID: 28982910
[TBL] [Abstract][Full Text] [Related]
15. Tumor lysis syndrome in the era of novel and targeted agents in patients with hematologic malignancies: a systematic review.
Howard SC; Trifilio S; Gregory TK; Baxter N; McBride A
Ann Hematol; 2016 Mar; 95(4):563-73. PubMed ID: 26758269
[TBL] [Abstract][Full Text] [Related]
16. Spontaneous tumour lysis syndrome in hepatocellular carcinoma presenting with hypocalcemic tetany: An unusual case and systematic literature review.
Agarwala R; Batta A; Suryadevera V; Kumar V; Sharma V; Rana SS
Clin Res Hepatol Gastroenterol; 2017 Jun; 41(3):e29-e31. PubMed ID: 27743982
[TBL] [Abstract][Full Text] [Related]
17. Urate oxidase for the prevention and treatment of tumour lysis syndrome in children with cancer.
Cheuk DK; Chiang AK; Chan GC; Ha SY
Cochrane Database Syst Rev; 2014 Aug; (8):CD006945. PubMed ID: 25121561
[TBL] [Abstract][Full Text] [Related]
18. Spontaneous tumour lysis syndrome in small cell lung cancer: a rare phenomenon.
Dhakal P; Rai MP; Thrasher M; Sharma M
BMJ Case Rep; 2018 Jun; 2018():. PubMed ID: 29898908
[TBL] [Abstract][Full Text] [Related]
19. Predictors of laboratory spontaneous tumour lysis syndrome in children with high-grade tumours in Uganda.
Apiyo M; Bongomin F; Balagadde J; Mupere E; Ndeezi G
Trop Doct; 2021 Oct; 51(4):501-507. PubMed ID: 34233540
[TBL] [Abstract][Full Text] [Related]
20. [Acute renal failure in paediatric oncological disease].
Stefanowicz J; Maciejka-Kapuścińska L; Rückemann-Dziurdzińska K; Drozyńska-Duklas M; Zurowska A; Balcerska A
Med Wieku Rozwoj; 2007; 11(3 Pt 2):337-41. PubMed ID: 18663277
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
